COVID

Collaborators

Leaders in drug development offering expert, discounted, and pro-bono services to accelerate treatments and vaccines in the global fight against COVID-19.

View Offerings
Offering type
Category
161 results
Posted Friday, July 31
Craig Serra is offering pro-bono consultancy in the clinical development operations and technology area
Craig has been in the industry for 18+ years in clinical development operations in both the pharma and CRO space. With knowledge spanning functions such as data operations, monitoring (remote and risk based), and clinical technology, Craig can help with overarching strategy, vendor selection, and tactical implementation. Even just as a person to bounce some ideas off of, Craig is happy to help COVID-19 researchers any way he can.
Contact
Posted Tuesday, July 28
Azur Clinical Services offers free statistical consulting and discounted offerings for COVID-19 efforts
• Azur Clinical Services is offering the following services for COVID-19 research • Statistical Consulting : Designing adaptive study, expert opinion on data handling under pandemic situation, Sample size estimation, Understanding and evaluating treatment based effect, Covid impact analysis, Sensitivity analysis for covid impacted clinical result, Handling missing and NR (due to covid and / or non-covid) values, complete statistical solutions. • Handson statistical work : Sample size calculation, Protocol inputs, SAP, TLF mock shells, statistical analysis, SAR or CSR input
Contact
Posted Wednesday, July 15
RUCDR Infinite Biologics supports COVID-19 diagnostic testing, sample management, Multi-omic analytical services, biobanking and advanced cells line services
As the world’s largest university-based biorepository, RUCDR has been perfecting the science of biobanking, bioprocessing and analytics since 1999. As experts in sample management strategies we were quick to innovate with the first FDA approved Saliva Collection device which now includes at-home saliva sample collection with our healthcare partners. As a Next Generation Central Laboratory, we offer a bespoke and tailored service transforming every sample into a renewable resource for life sciences diagnostic, discovery, and development. • Sample Management Strategies • High Throughput DNA/RNA extraction • Multi-omic Analytical Services • Advanced Cell Culture & Stem Cell services • Bioinformatics & Analytical services • Biobanking
Contact
Posted Tuesday, June 30
Free Clinical Trial SaaS to help Sponsor and Academic Clinical Operations/Research teams stay hyper organized and informed about their clinical trial subjects
We’re offering a free subscription to our Clinical Trial SaaS (software-as-service) for the lifetime of a COVID-19 trial. Offer expires after it has been redeemed for two clinical trials. Our cloud-based Clinical Trial SaaS was designed to help Sponsor and Academic Clinical Operations/Research teams quickly consolidate, organize, and meaningfully report on all their subjects’ operational data without complex integrations. Teams no longer need to rely on Excel or navigate to separate data sources/systems. All our SaaS subscriptions include custom protocol-specific setup and dedicated support.
Contact
Posted Monday, June 15
Sanguine Biosciences provides biopharma researchers with non-invasive samples from recovered COVID-19 patients
Sanguine Biosciences, a California-based technology company focused on patient engagement and digital health, connects the researchers that need access to non-invasive biospecimens with the patients that would qualify to be test subjects. Sanguine’s concierge service provides mobile health care workers to visit the patient in the comfort of their own home.
Contact
Posted Friday, May 29
Interek provides support for companies working on COVID-19. We provide a wide range of services for Vaccine & Therapeutic Development
Providing COVID-19 Vaccine and Therapeutic testing and development outsourcing solutions. Enabling your business to progress the fight against COVID-19 through GLP, GCP and GMP vaccine or therapeutic support including bioanalysis, characterization, release testing and auditing. Intertek can design and deliver the highest quality, phase appropriate characterisation and QC/release testing solutions. With proven scientists who have contributed to the development of existing flu vaccines, our solutions are built on experience, from early stage formulation development, clinical trials to manufacturing and beyond. We work across many modalities including small molecule, viral vector products, oligonucleotides, mRNA, recombinant and natural proteins, inhaled or nasal drugs, lipid nanoparticle or liposome encapsulated products and so whatever your modality, we have the expertise ready to assist you.
Contact
Posted Monday, May 25
Unique AI analytics platform offered to medical research community
PrecisionLife is offering free use of its unique AI analytics platform and support from its data and biomedical science teams to the on-going collaborative efforts of the medical research community in the fight against COVID-19 coronavirus.
Contact
Posted Monday, May 25
MyCRO Offers Discounted Site Management, Feasibility, Logistic Support and Central Management in Turkey to all COVID 19 related trials
Founded in Ankara, MyCRO’s mission is to provide the highest quality at every stage of clinical research. We are bringing to you our 8 years of clinical research logistic support and 10 years of experience in Clinical Research Management in Phase I-IV, Observational, and Medical Device studies. We conduct studies in more than 20 cities which means we have a wider range than most of the CROs in Turkey. Our primary advantage on the other CROs in Turkey in the situation of initiating a COVID-19 study. We can help with the process from A to Z after a Sponsor decides to open a new site in Turkey or initiate a new study for COVID-19. We will be supporting them by starting to prepare the EC and MOH files, doing the submissions, selecting the sites as well as finding the most successful and eager PIs, doing SIVs, providing and training the site Staff, etc. Hence, we may be the best option in Turkey.
Contact
Posted Friday, May 22
Full-service CRO with extensive vaccine and infectious disease experience
ProTrials’ senior management has been monitoring the global COVID-19 pandemic with a focus to protect study patients and our employees, while ensuring business continuity with our sponsor partners. We continue to monitor the latest guidance from international health organizations and the evolving impact of the pandemic, and we recognize that your project may have unique considerations. ProTrials has supported vaccine and infectious disease trials for 24 years and more than 70% of our clinical staff have related trial experience. We have managed vaccine trials focused on flu, HIV, meningitis, oncology, hepatitis B, smallpox, anthrax, among others, and are actively preparing to support new trials focused on COVID-19. Working with our sponsor partners to implement programs with virtual patient assessments and remote trial management activities is the new normal.
Contact
Posted Friday, May 22
Global COVID-19 clinical trial tracker launched by Cytel
Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.
Contact
Posted Tuesday, May 19
Non-GMP small molecule development services to expedite potential COVID-19 treatments
CatSci Ltd is a leading process Research and Development CRO for the pharmaceutical industry. We work with small, mid-sized, large and virtual pharma, applying our expertise in delivering drug discovery and development projects to develop manufacturing processes for small molecule APIs. With the outbreak of COVID-19, we are offering a host of small molecule chemistry services including route scouting and selection, process design, scale-up and non-GMP material supply at cost in order to help turn your small molecule asset into a potential COVID-19 medicine. We will strive to ensure your therapeutic can be manufactured in an economically viable and environmentally sustainable manner, and its manufacturing control strategy can be implemented over the lifecycle of the medicine.
Contact
Posted Thursday, May 14
In vivo / in vitro immunology studies and molecular testing for Sars-CoV-2 infectivity
Texcell can test the infectivity of Sars-CoV-2 on living cells, to evaluate the potency of active molecules to block virus entry or virus replication, for the detection of immuno-active patient sera.
Contact
Posted Thursday, May 14
Noble.AI to provide free AI tools to scientific community to speed discovery of a Covid-19 cure
Noble.AI, an industry leader in AI powered software that accelerates science and helps researchers make more important discoveries faster, announced that today they are launching the Immunity Initiative – www.immunity-initiative.org – providing free cloud-based AI models and data to research labs and scientists around the world to speed discovery of the most promising treatments and cures for Covid-19.
Contact
Posted Tuesday, May 12
Coronavirus custom cloning and cell line services for preclinical and clinical COVID research
VectorBuilder is the world's leading provider of vector construction and virus packaging services. Our highly intuitive online design tool on VectorBuilder.com provides a user-friendly workflow to design your desired vectors with just a few mouse clicks and all for free. Our ever-expanding collection of backbones, promoters and ORFs ensures you save money and valuable time compared to Do it Yourself (DIY) cloning. All vectors come with a 100% sequence guarantee and VectorBuilder is also a source for premium downstream services including library generation, targeting vector and CRISPR vector design as well as BAC modification. With the outbreak of COVID-19, we are now also offering a host of services for preclinical and clinical CoV-2 research. VectorBuilder’s flexibility offers custom vector design at its best and fastest so you can focus more on critical experiments and data analysis.
Contact
Posted Friday, May 8
seQure offers pharmacovigilance support in clinical trials related to a potential COVID-19 treatment
seQure is a niche service provider in the Life Sciences sector offering expert pharmaco- and device vigilance, quality assurance, and regulatory solutions to drug and device companies. We have exceptional expertise in vigilance, with a team that boasts more than 25 years of experience. We are already involved in a clinical trial as a pharmacovigilance partner related to a potential COVID-19 treatment. Our pharmacovigilance team guarantees impeccable quality and uncompromising attention backed by years of industry experience.
Contact
Posted Wednesday, May 6
Reduced rates & free feasibility for COVID-19 trials from Wuxi Clinical
In response to COVID-19, WuXi Clinical has developed a comprehensive network of investigators capable and willing to conduct clinical trials across all phases in both the USA and China. We will waive all feasibility costs for any contracted COVID-19 study beginning in 2020. Additionally, we will provide discounted rates for all contracted services on these trials.
Contact
Posted Wednesday, May 6
Poseidon CRO offers its expertise in North Africa, Central, and Eastern Europe to all COVID 19 related trials for IVD/vaccines/drugs/medical device
Poseidon CRO has a wide regional reach in North Africa, Central, and Eastern Europe, providing a large spectrum of services to the drug development, medical device, in-vitro diagnostics industries. We have robust expertise in the fields of small molecules, IVD validation, biological, and biosimilars clinical testing. Our network of sites and experienced professionals can be immediately involved in research projects including COVID 19 patients and give their expertise in the validation of proposed solutions. We are open to collaborate with other companies/sponsors/Health organizations offering: 1) Expedite regulatory approvals 2) Implementation and follow up of virtual trials 3) Optimization of patient enrolment and Site management 4) Assurance of business continuity regarding clinical trial logistic support 5) Adequate project management insuring optimal sponsor oversight 6) Reach out to us so we gather our efforts to bring in to life innovative and pertinent solutions to cope with these unprecedented challenges.
Contact
Posted Monday, May 4
Ready to contribute to the global community - Japanese phase 1 site for COVID-19 studies
Supporting clinical studies related to diagnostics, novel/repurposed drugs, and vaccines that focus on bringing an end to the global COVID-19 pandemic. 1) Accelerated (<30 days) clinical trial notification timeline to start FIH studies of COVID-19 candidate products 2) Expedited IRB application reviews for COVID-19 trials 3) Precision Bronchial Micro Sampling (BMS) assessment to evaluate the effective delivery of target medicines to lung cells 4) Extensive Vaccine Study* experience with both young and elderly male/female subject groups, as well as children (*over 1,000 subjects per study) 5) Supported expertise of SOUSEIKAI’s Clinical Epidemiology Research Center, whose director was a former member of the WHO Strategic Advisory Group of Experts (SAGE) Working Group for H5N1 influenza vaccines.
Contact
Posted Friday, May 1
Site contract negotiation executed quickly and efficiently
Triacle is a specialist consultancy focused exclusively on site contract negotiation. Our pan-European team of highly experienced negotiators ensure site contracts are finalised quickly and efficiently. At this time of heightened activity, having a team of dedicated, multilingual experts in site contract negotiation and execution working with you makes a real difference.
Contact
Posted Friday, May 1
PYRAMID Laboratories, Inc. is a CMO able to provide fill finish services for injectable drug products, we offer 10% discount on our services for products related to COVID-19
PYRAMID Laboratories, Inc. is a CMO focused on parenteral drug products, offering a comprehensive pipeline of services. Established in 1988 in Southern California, we offer aseptic vial and syringe filling, as well as lyophilization capabilities, for both Clinical and Commercial products. Our laboratory offers product development and analytical capabilities performing dozens of methods in a cGMP/GLP setting. For over 30 years, we have provided clients with Top Quality services assuring that their critically important parenteral products reach patients in need.
Contact
Posted Thursday, April 30
PRG International Site Network supporting sponsors and CROs on vaccine and therapeutic treatments against COVID-19
Physicians Research Group (PRG) is a leading international research management organization and site network. We are headquartered in Tempe, Arizona, and have locations throughout the US and partnerships with sites in; Australia, Canada, South Africa, South America, and New Zealand. PRG and our partners have extensive experience in phase I-IV trials, including vaccines and infectious disease indications. PRG Provides: Centralized HIPPA compliant study systems Centralized contracting and budgeting across all of our site network (including international locations) - reducing overall study costs Virtual subject visit capable Remote Monitoring and real-time data sharing Inpatient, outpatient, and hospital locations Access to over a 2M patient population PRG is committed to providing high-quality research and development data on potential treatments and vaccines against COVID-19. We are here To learn more about how PRG can help you in the fight against COVID-19, contact Robert Wallace, President and CEO at [email protected]
Contact
Posted Tuesday, April 28
Prepare for COVID-19 trials: Free virtual trial training program available to any clinical research professional worldwide
For clinical research sites: VirTrial is offering a free four-module training program covering general telemedicine etiquette and guidelines, as well as how to utilize the VirTrial Virtual Care Management (VCM) platform. The program is available to any clinical research professional worldwide to aid in their preparation for COVID-19 trials or any other trial that requires remote visits. Upon completion, VirTrial will provide a Virtual Trial Capable certificate and digital badge that can be shared online to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials. For Sponsors/CROs: VirTrial is offering the industry's most robust telemedicine platform available (utilized for 7 years in healthcare delivery) customized for clinical trials. Through the secure platform we can offer a complete virtual experience for both patients and monitors needing to interact with their study site.
Contact
Posted Monday, April 27
Offering COVID-19 related probes, genes, and protein products separately and as part of our convenient SARS-CoV-2 Real-Time RT-PCR Detection Assay Kit.
Since the outbreak of COVID-19, Synbio Technologies has set up a special coronavirus emergency project team, working against time to produce virus-related probes, genes, and protein products. We are currently providing comprehensive COVID-19 DNA solutions and working with our clients and partners from hospitals, scientific research institutes, and enterprises to fight the disease.
Contact
Posted Thursday, April 23
Providing sites for COVID-19 trials and global crisis communication solutions
ISS has sites located across North America, including several in highly impacted areas, that are fully operational and equipped to conduct COVID-19 vaccine, treatment, and diagnostic studies. To assist with these critical, fast-paced studies, our sites are expediting contracting (avg 3-5 BD) and activation timelines (1-2 weeks). Capabilities: 1) Testing centers for COVID-19 in several states 2) Hospitals with access to severe and acute patients 3) Facilities that meet COVID-19 isolation requirements 4) Access to diagnostic machines that can provide rapid positive or negative diagnoses (within 5 to 15 minutes) 5) Full capability to conduct virtual visits or utilize telemedicine
Contact
Posted Tuesday, April 21
Prepared & equipped to join the battle against COVID-19
DM Clinical Research (DMCR) has led with an agile, carefully-laid plan to deal with the COVID-19 Pandemic. With patient and staff safety and well-being as the one priority, avenues to minimize contact while continuing to keep protocol schedules on track has been the focus. DMCR's network of sites remain fully operational by innovatively leveraging econsent, eSource, telemedicine platforms, “drive-thru” visits, and site- to-subject drug transport. In addition, DMCR has been in close collaboration with Sponsors seeking site input on adapting protocols. To learn more about DMCR, site capabilities, and opportunities to partner, please contact Marianne Tadros, Director of Corporate Development, at: [email protected]
Contact
Posted Tuesday, April 21
ERT delivers actionable insights to identify COVID-related clinical trial risks
ERT’s complimentary COVID-19 Dashboard integrates data on coronavirus infection rates in geographic areas surrounding study investigative sites, so sponsors can identify and proactively intervene where patient and site compliance to study protocols may be at risk. The Dashboard helps sponsors identify areas of imminent risk caused by reduced patient site visits, enabling them to intervene and keep patients engaged throughout clinical trials. Study-specific reports present convenient views of COVID-19 cases in relation to study site locations, flag sites and patients with potential device/data risks, and enable a targeted intervention approach toward real-time study monitoring to ensure data quality, regardless of patient access to investigative sites.
Contact
Posted Friday, April 17
Illumina makes software toolkit available free of charge to support worldwide efforts to combat COVID-19
Illumina, Inc. announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to critical public databases. Illumina is making the toolkit available at no cost to the global research community in support of efforts to combat the pandemic.
Contact
Posted Friday, April 17
HungaroTrial is Fasting Tracking COVID-19 Trials in Central Eastern Europe
HungaroTrial is a market-leading regional CRO in the CEE region. We are able to support COVID-019 projects with our expert team, that is local to each country we offer our clinical operation services in. This expertise is paired with unparalleled medical support including a certified infectious disease specialist. Moreover, we can offer you a Regulatory Fast Track for COVID-019 trials in Hungary and Romania. Your sites could be initiated within ONE MONTH of the contract signature with HungaroTrial. You would have your study setup with the first site initiated and the FPFV within one month of the study start. As an example of this support we are proud to have already submitted a Phase III application under the COVID-019 fast track application and received approval in 4 days.
Contact
Posted Thursday, April 16
Tekton Research is open and ready to enroll the current and upcoming COVID-19 clinical trials
We would like to support your clinical research trials (Phase 1 to 3) and have 12 clinical research sites in 4 different states. We also belong to a site network that consists of 6 companies (including Tekton Research), 47 unique site locations, 92 investigators and 19 medical specialties. At Tekton Research our investigators and research coordinators have years of experience with high volume and fast enrolling clinical vaccine trials and successfully recruit from pediatric, adult and elderly populations. We deliberately focus on knowledge, skill, integrity and deliver high quality data to our clients.
Contact
Posted Wednesday, April 15
Free accelerated data transfer software for COVID-19 researchers
Data Expedition, Inc.® (DEI®), announced today that the company is offering free licenses of its accelerated data transport software, including ExpeDat and CloudDat, to scientific researchers trying to fast-track a vaccine for COVID-19.
Contact
Posted Wednesday, April 15
Premier provider of unified eClinical solutions & services
Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: Data Management, Data Analytics, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/
Contact
Posted Tuesday, April 14
Scope International has a team of experts in the respiratory and infectious disease spaces who can work with COVID-19 sponsors to act quickly to expediate trial start up activities, optimize enrollment and best navigate the rapidly changing clinical trial landscape
As a full-service CRO whose approach focuses on operating with efficiency coupled with our existing site and investigator relationships, Scope International has the ability to work with sponsors to quickly start up trial activities for COVID-19 related studies in this critical time. Our centralized and risk-based monitoring abilities allow for a monitoring plan to best navigate and fit the current landscape. With teams strategically positioned in the US and across Europe, we are able to cover sponsors’ needs around the globe. We provide individualized attention and collaborate with sponsors to form partnerships which ultimately end up serving the people in need around the globe.
Contact
Posted Tuesday, April 14
Almac Group’s Comprehensive service offerings to support expedited COVID-19 research programs and treatments
As the global Coronavirus crisis continues to escalate, Almac Group has commenced work on supporting 34 separate crucial research projects for a variety of global pharmaceutical, biotech and research institutions. Below is a highlight of our solutions currently supporting COVID-19 related programs: 1) Flexible Distribution: Including Direct to Patient via Site (DTP) or Almac to Patient (ATP), which allows the shipment of supplies directly to the patient’s home from an Almac facility, whilst upholding GXP compliance. 2) Just in Time (JIT) Manufacturing: Full late stage customization of clinical supply. 3) Temperature Management: End-to-end regulatory compliant solution with full visibility of temperature data within the supply chain. 4) Expedited implementation of Interactive Response Technology (IRT): Expedited process to design, validate, and deploy fully-functioning IRT systems for patient randomization and clinical trial material management. 5) Almac ONE: A unified clinical trial solution, integrating patient recruitment, clinical supply and Interactive Response Technology (IRT). 6) Peptide & protein technology: High-throughput manufacture of peptides, long peptides, conjugation and peptide cocktails. 7) Biocatalysis: Enzyme discovery, engineering and screening, and enzyme applied synthesis of complex chiral products, all based on Almac’s selectAZymeTM technology. 7) Analytical services: Analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Contact
Posted Tuesday, April 14
4G Clinical Launches Direct-to-Patient (DtP) Clinical Trial Platform
Prancer RTSM™’s Direct-to-Patient (DtP) functionality enables clinical trial continuity during the COVID-19 pandemic by allowing drug to be shipped directly to a patient’s home, alleviating some of the challenges faced by sponsors, sites and patients. Sponsors can set up DtP functionality for studies pre and post go-live, for certain periods of time, for all or selected visits, with the ability to turn it off while the study is running with only a change in configuration. Prancer RTSM™ supports all main Direct-to-Patient (DtP) models including Depot-to-Patient, Central-Pharmacy-to-Patient, Site-to-Patient and Hybrid. This can be set on the study, country, site, and patient visit level allowing different DtP models within the same study. This becomes especially critical to adhere to different rules and regulations across the globe. All other functions within Prancer RTSM™ work seamlessly under this new model. This includes temperature management, shipment receipt, resupply and forecasting, accountability (assuming kits returned to the site), kit status management, inventory management, etc. With Prancer RTSM™’s DtP functionality, sponsors now have the following benefits: 1) Ability to continue clinical research by sending drug to patients during the COVID-19 pandemic 2) Proactive response to patient enrollment challenges and site capacity limitations 3) Flexibility to adjust DtP models based on country regulations and duration needed 4) Compliant handling of patient privacy information for shipping drug 5) Full visibility into the location of drug at all times 6) Automatic resupply of drug through different channels (site, depot, central pharmacy) 7) Option to utilize DtP as a way to reach more disperse patient populations and be more patient centric
Contact
Posted Tuesday, April 14
Preclinical infectious disease expertise
Lovelace Biomedical has a history of working with SARS and the Coronavirus strain from 2003. We have one of the only non-governmental, and non-academic ABSL-3 Labs in the US and can easily study and research the novel coronavirus.
Contact
Posted Monday, April 13
Eurofins Discovery Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services
The Eurofins Discovery solution portfolio that can support COVID-19 research include: 1) Safety profiling 2) Efficacy testing 3) Custom assay development 4) Drug repositioning services 5) Bioassays and target specific assays 6) Cytokine storm assessment. As recommended by the FDA and EMA, early-stage evaluation of cellular activation, proliferation, and cytokine release, as offered by Eurofins Discovery, may help reduce the risk of adverse reactions in later clinical development.
Contact
Posted Monday, April 13
Clinilabs is offering drug development services at cost for COVID-19 research
COVID-19 is having an impact on the entire world and a particularly profound affect on New York City, the home base of our organization. We join so many of our friends and colleagues in the life sciences industry in the fight against COVID-19 by offering our people, our services and our clinical research units at cost to those who are developing treatments and vaccines for this disease. Clinilabs Drug Development Corporation is a global, full-service contract research organization, dedicated to bringing new therapies to patients in need. While we are focused on speeding new CNS medicines to market, we join the world in the race to find new therapies and a vaccine for COVID-19. Clinilabs partners with our customers to deliver a full, first-in-human to Phase 3 spectrum of high quality, timely and cost-effective clinical drug development services. At Clinilabs, experience, scientific knowledge and operational expertise combine with accountability, responsibility and integrity to create a powerful value proposition for the pharma and biotech companies we serve. We are process driven yet structured to be nimble, providing personalized service to customers of all sizes for projects of all scope. We own and operate two, 50-bed clinical research units for early phase research, including vaccine development, in New York City and Eatontown, NJ. Clinilabs has conducted more than 650 clinical trials and played a pivotal role in the approval of 19 new therapies in 10 different indications to help transform the lives of patients.
Contact
Posted Monday, April 13
Parexel is focused on supporting the development of new therapies from regulatory and consulting services, global clinical trials management, direct to patient shipments and remote monitoring to commercial and market access expertise
Parexel continues to be committed to our clients’ business while putting the safety of patients, client partners and our employees at the heart of everything we do. As a leading CRO, we are in the business of improving the world’s health and we are dedicated to actively contributing to vaccine and drug development efforts for COVID-19. Parexel has the experts, innovations and processes in place to navigate the new and rapidly changing landscape. Our teams are deploying remote qualification visits and monitoring along with best practices in risk-based monitoring surveillance where appropriate and new and innovative solutions such as decentralized trials. Our team of 1,000+ Regulatory & Access experts — many of whom bring recent FDA and MHRA experience — can provide deep experience as we navigate through this challenging time. Visit our COVID-19 Resource Center to get latest news, translated guidance information, and expert interpretations from our former regulators. For more information, visit our website and follow us on LinkedIn, Twitter and Instagram.
Contact
Posted Thursday, April 9
Altasciences, a fully integrated early phase drug development cro offering preclinical safety testing, clinical research, bioanalysis, and manufacturing services
Altasciences has a COVID-19 Executive Response Committee to accelerate your projects and enable you to quickly reach key milestones by performing different stages of drug development simultaneously, while ensuring safety. We have the team in place to help you make informed decisions quickly and within constrained timelines, by providing you with fully integrated solutions from preclinical to clinical Proof of Concept (POC), including bioanalytical support. Our expertise to help you fight COVID-19 includes: 1) A preclinical safety testing facility also known as a primate center of excellence 2) Clinical facilities in the U.S.A. and Canada with experience in infectious diseases 3) Microsampling capabilities for subject adherence to dosing protocol from home 4) The full array of bioanalytical services to support your needs from discovery through regulated bioanalysis, including validated assays on drugs being investigated for COVID-19 treatments Altasciences is a mid-size, early phase contract research organization that recently completed Phase I work on a therapeutic intended for the treatment of Acute Respiratory Distress Syndrome associated with COVID-19, and is collaborating on several other programs, including monoclonal antibodies, gene therapy, and vaccines.
Contact
Posted Thursday, April 9
Federal Equipment Company offers thousands of pharmaceutical processing and packaging machines to meet the needs of manufacturers tackling COVID-19
Federal Equipment Company offers 60 years of expertise buying and selling pharmaceutical processing and packaging equipment. We optimize the value you recoup for surplus equipment, while making the removal process easy. And we ensure you get the equipment you need quickly when sourced from our broad, on-hand inventory of reliable used machines.
Contact
Posted Thursday, April 9
Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemic
The COVID-19 Module within the Metys platform will provide up to three users per company with access to all drugs and markets within any U.S. geographic region down to CBSA (core-based statistical area). The module will include history back to October 2018 to ensure access to comparative flu season trends in prior years, with March 2020 data becoming available on April 10. Companies may publish or report insights or findings from the data with prior permission from Symphony.
Contact
Posted Wednesday, April 8
Tetra Bio-Pharma volunteers to guide medical device/ health-related manufacturers
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development has joined the battle to fight the novel COVID-19 virus. The Company will mobilize its expertise in regulatory affairs and quality assurance to support Canadian businesses seeking Health Canada approval for specific products used to mitigate the ongoing COVID-19 pandemic.
Contact
Posted Wednesday, April 8
International full service CRO with experience running COVID-19 clinical and non clinical projects
CUP fast approach, response to therapeutic program applications in 48 hours, experience in running COVID-19 clinical and non-clinical projects, geographical position in a COVID-19 strongly affected area (Europe and in particular Italy and Spain).
Contact
Posted Tuesday, April 7
iReceptor Plus to offer tools and infrastructure for sharing antibody and t-cell receptor sequencing data from COVID-19 patients
The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to facilitate the sharing and analyses of antibody and T-cell receptor sequencing (AIRR-seq) data from COVID-19 patients as soon as these data become available.
Contact
Posted Tuesday, April 7
Coronavirus treatment: Harmonic Pharma makes drug data available to researchers
Harmonic Pharma has announced that it is making "data immediately and free of charge " to virology researchers and clinicians its data on drugs used to fight Covid-19. Joined on the phone Monday, April 6, Dr. Sinan Karaboga gives us the details of this initiative. " We have at our disposal a database of medicines which lists all the medicines which are on the market today and used for any form of pathology ", informs the professor.
Contact
Posted Monday, April 6
BioTel Research offers remote cardiac safety monitoring
BioTel Research is actively monitoring COVID-19 patients across the United States to help hone their treatment and ensure their survival. Some drugs being used to relieve COVID-19 symptoms, such as hydroxychloroquine and azithromycin, are known to prolong patients’ QT intervals, which can cause sudden cardiac death. BioTel’s MCOT™ (Mobile Cardiac Outpatient Telemetry) is a high-compliance, body-worn, Bluetooth enabled, heart monitor patch that issues real-time alerts that can be vital for these patients’ safety. BioTel Research is the only cardiac core lab whose proprietary mobile telemetry solution is FDA 510K approved to measure, analyze, and report QT intervals. MCOT and other potentially life-saving solutions are available for rapid deployment in COVID-19 clinical trials.
Contact
Posted Monday, April 6
AES is providing flexible patient recruitment and site conduct solutions for clinical trial sponsors as COVID-19 puts trial continuity at risk
At Accelerated Enrollment Solutions (AES), our goals are to maintain a fully functioning set of 180+ research sites worldwide, to continue to screen new patients, and to conduct trials as planned. We are employing all of the tools at our disposal to ensure study continuity and provide enrollment acceleration during and after the current crisis, with emphasis on: 1) Providing remote site start-up visits 2) Expanding patient telehealth and virtual solutions 3) Accommodating patients from non-AES sites that are shutting down 4) Offering in-home solutions. Sponsors benefit from maintaining required data continuity, allowing current patients to continue their research commitment, and being able to utilize AES sites worldwide to screen and enroll additional patients as needed.
Contact
Posted Monday, April 6
Clients access free registration to CSSi’s patient engagement and retention platform for all study participants enrolled in their COVID-19 studies
CSSi has a patient engagement platform for studies that require continued patient education, communications and retention in a study. The platform is a tool used to keep patients motivated and compliant throughout the duration of the study. CSSi will provide no charge for patients enrolling into CSSi’s patient engagement & retention platform for any COVID-19 study.
Contact
Posted Monday, April 6
Benchmark Research: Raising the standard in vaccine research
Since 2004 we have enrolled a record 25,000+ subjects in over 300 vaccine trials. Industry leader in Phase I – IV vaccine research 1) High-volume patient recruitment and retention 2) Benchmark Research Call Center allows us to go above and beyond our vast database for recruitment 3) All demographics and age groups 4) Successfully completed numerous ground-breaking vaccine trials 5) Adaptive services that meet changing industry needs 6) Unique geographic spread of sites 7) Centralized operations, contracting, and marketing/advertising 8) PBMC Capabilites 9) IBC Registered
Contact
Posted Monday, April 6
George Clinical is offering remote clinical trial execution and scientific leadership on COVID-19 studies from start-up to closeout and the ability to get First Patient In for COVID-19 trials in record time
The George Clinical team has an all hands on deck approach to helping our sponsors get their lifesaving treatments into the hospitals as quickly as possible. We offer special rates for these COVID-19 trials that will reduce the cost of completing your trial. Our scientific leaders in respiratory disease and multiple other therapeutic areas, including cardiometabolic and renal and immune system issues, stand ready to help you design your trial and get your protocol ready for submission to the authorities. We are currently working with governmental regulatory bodies in the USA, Europe, and across the Asia Pacific. If you want to move fast with strong scientific and operational support, George Clinical is your choice for COVID-19 trials from start to finish including virtual investigator meetings, remote start-up, rapid EDC and systems build, centralized monitoring, all the way through to closeout.
Contact
Posted Monday, April 6
Meeting Protocol Worldwide: Offering virtual investigators’ meetings at a discounted rate for sponsors developing COVID-19 treatments
MPW provides on-demand virtual training solutions and real-time virtual meetings within the life sciences industry.
Contact
Posted Monday, April 6
Supporting Scientific Research of COVID-19 with World-Leading Data Extraction Services
To help with the ongoing fight against COVID-19 (coronavirus), Scrapinghub is offering its web scraping services FREE to members of scientific, research, non-profit or healthcare teams for use in combating the COVID-19 pandemic.
Contact
Posted Friday, April 3
FUJIFILM Wako is offering a range of kits and lab products in support of COVID-19 vaccine research
FUJIFILM Wako is a recognized global supplier of high purity chemicals and reagents, with our North American corporate office located in Richmond, Virginia. Offering: 1)High sensitivity lysate reagent (0.015EU/ml) for the detection of bacterial endotoxin in COVID-19 vaccines and other parenteral therapeutics under development - offered in 80-test and 200-test kits at deep discounts and while supplies last 2) 0.06EU/ml lysate reagent for the detection of bacterial endotoxin in COVID-19 vaccines and other parenteral therapeutics under development - offered in 80-test kits at deep discounts and while supplies last 3) Endotoxin indicators for performing validation for depyrogenation processes of dry heat oven cycles to insure that a cycle is effectively inactivating and/or destroying endotoxin in any glassware, test tubes or medical devices being used in vaccine preparation or storage - offered in kits of 25 ready-to-use vials at deep discount while supplies last. 4) limited quantities of pyrogen-free pipette tips, pyrogen-free microplates and pyrogen-free lysate reagent water to support endotoxin testing on COVID-19 vaccines and other parenteral therapeutics in development will be donated at no cost.
Contact
Posted Friday, April 3
Experic's services for supporting COVID-19 treatments and existing drugs with increased demand for fighting COVID-19
Experic, a CMO and pharmaceutical supply services company located in Cranbury, NJ, supports pharmaceutical manufacturing from clinical though commercial scale as well as packaging and distribution. We provide these services across a range of dosing and packaging formats, including capsule filling, powder and pellet dosing (including dry powder inhalers), autoinjectors, and pen assemblies. We stand ready to support your COVID-19 projects now with: 1) Powder filling with 100% weight verification 2) Dry Powder Inhalation (DPI) manufacturing 3) Primary and secondary packaging 4) Labelling and kitting 5) Warehousing and storage (RT and 2C - 8C) 6) Clinical supply logistics
Contact
Posted Friday, April 3
Flywheel's platform, including Imbio's lung analysis tools, will be made available free of charge to COVID-19 academic and clinical researchers.
The companies have independently developed technologies over the past 5 years and are growing rapidly in their respective markets. Given the unfolding pandemic, Flywheel, Imbio and their parent company, Invenshure, have decided to combine technologies to offer researchers powerful tools to aggregate and analyze COVID-19 related data.
Contact
Posted Friday, April 3
Enzyme Offers Support for Teams Dealing with COVID-19
In light of these challenges, we want to support companies developing solutions aimed at the diagnosis or treatment of the novel coronavirus SARS-CoV-2 and its related disease COVID-19. We are offering: 1) Free consulting session regarding Emergency Use Authorization (EUA) filings with FDA 2) Free onboarding and 2* months of free access** to Enzyme’s cloud-based electronic Quality Management System (eQMS) platform 3) Free access to the Enzyme Community with educational material and regulatory how-tos
Contact
Posted Friday, April 3
ERT offering At-Home Respiratory Assessments
ERT’s At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patient access to investigative sites is limited due to COVID-19 stay-at-home mandates. Precise, repeatable spirometry data can be collected when trained healthcare professionals use study devices in patients’ homes and provide coaching on how to perform the proper breathing maneuvers. ERT MasterScope™ and SpiroSphere® meet these needs by enabling clinician-administered spirometry assessment during patient home visits. The portable, battery-powered solutions provide clear, real-time quality feedback to obtain high-quality spirometry readings from patients and transfer data to the ERT Portal directly from patients’ homes. Additional integrated devices enable trained users to capture ECG, FeNO and Forced Oscillometry data with MasterScope. The at-home approach can be easily added to currently active studies.
Learn more: www.ert.com
Contact
Posted Friday, April 3
WCCT offers COVID-19 screening tests at its Phase 1 clinical unit
WCCT Global operates a full-service clinical pharmacology unit dedicated to early phase research in Cypress, CA. The facility has implemented three unique COVID-19 screening platforms to ensure that trials can be conducted in a safe environment for both staff and subjects. The facility has participated in numerous trials in the areas of infectious diseases and vaccine development. Other features: 1) Active database of 55,000+ research volunteers 2) Three distinct research wards which can be used to separate subjects and are customizable to the needs of the protocol 3) Access-controlled pharmacy with USP-797 clean room on-site 4) Staff trained in: emergency response, use of PPE, and nasopharyngeal swab collection 5) In-house CAP Accredited and CLIA Certified Safety Reference Laboratory 6) Respiratory panel testing 7) Ability to isolate Peripheral Blood Mononuclear Cells (PBMCs) 8) Long-term sample storage 9) In-house scientific, regulatory, and medical writing personnel
Contact
Posted Thursday, April 2
MedTrial Focus is offering free site ID services to Sponsors and CROs with COVID-19 studies
Free site ID services to Sponsors and CROs with COVID-19 studies will grant access to highly experienced investigators and sites. Investigators are available to provide feedback on study design.
Contact
Posted Thursday, April 2
What CTI Can Do to Help Fight the Impact of COVID-19
CTI has a wealth of experience in rare diseases and infectious diseases. Below are some examples of how we can help as you prepare your program to fight COVID-19. 1) Submit FDA/EMA/Regulatory submissions - expanded indications for products to treat or prevent COVID-19 2) Manage expanded access programs to utilize products to treat COVID-19 3) Develop and manage any new US or global clinical trial for prevention or treatment of COVID-19. 4) In addition to our experience managing infectious disease studies, the CTI Clinical Research Center has extensive experience as a research site. 5) Create Database/EMR analysis of specific regions with COVID-19 6) Perform epidemiologic assessments of COVID-19 affected populations
Contact
Posted Thursday, April 2
CCT Research sites are committed to staying open to support enrollment for current and upcoming COVID-19 trials
We are a site network with 6 family/internal medicine-dedicated sites that are all currently testing for COVID-19. Our PIs and study staff have extensive research experience and understand the complexities of clinical trials. Please contact Tyler Marrs at [email protected] for site inquiries.
Contact
Posted Thursday, April 2
COVID-19: developers of medicines or vaccines to benefit from free scientific advice
EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat the disease) or vaccines (to prevent the disease) against the novel coronavirus disease (COVID-19). Developers of potential therapeutics or vaccines against COVID-19 are invited to contact the Agency as soon as possible with information about their proposed development, by emailing [email protected] In a first round of discussions, EMA can provide preliminary informal comments and feedback on the development. This will then allow the Agency to identify the products which are mature enough to benefit from fast-track scientific advice, to guarantee best use of this tool.
Contact
Posted Thursday, April 2
Nuventra offering numerous free regulatory and clinical services
Finally, we want to help our clients bring vaccines and therapies to patients in need as soon as possible. An important resource Nuventra offers is bandwidth. With the increased urgency to address the current outbreak, we have services to offer immediately. We can quickly support the development of a vaccine or treatment – from data analysis and pharmacometric modeling to help identify dosing paradigms to writing, programming and regulatory strategy. In addition, we will offer the following services free of charge for any drug development program intended to prevent or treat the novel coronavirus: 1) Review of clinical protocols 2) High level drug development gap analysis 3) General 30-minute Q&A with Nuventra drug development professionals (including former FDA reviewers) to help address any roadblocks or issues in the development of a vaccine or treatment.
Contact
Posted Thursday, April 2
PHARMASEAL supports life science businesses by offering no cost CTMS for COVID-19 clinical trials
PHARMASEAL International, provider of clinical trials management systems announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.
Contact
Posted Wednesday, April 1
Greenphire: Bring Care to Your Patients with ConneX Patient Direct
Today, we introduce you to ConneX Patient Direct. This new feature of our expert travel solution now provides specialized ground transportation direct to patients’ homes: 1) Drug courier service 2) Medical equipment home delivery 3) Site medical personnel transportation to conduct in-home visits Available on all six continents, providing your study with global coverage.
Contact
Posted Wednesday, April 1
Clinical Ink offers their expert de-centralized trial services
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our Lumenis™ eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules provide a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source. Our technology for decentralized trials, bring your own device (BYOD) ePRO, and direct data capture (DDC) have been in place for years, but we understand COVID-19 will accelerate the need for sponsors and CROs to adopt these methods. Your goal may be to decrease patient visits by one, or — given current circumstances — to eliminate them completely. Through our long-term, pioneering focus on direct data capture and fully integrated patient engagement, we have built a vast toolkit of solutions, technologies, and supportive industry guidance to make your decentralized trial a reality.
Contact
Posted Wednesday, April 1
InSphero offers free safety testing in 3D InSight™ Human Liver Models for exploratory COVID-19 treatments
Organizations working on new medications and vaccine formulations may request free safety testing using preclinical liver models that identify potential for toxic effects in humans.
Contact
Posted Wednesday, April 1
LabShares Newton Offers No-Cost Project-Based Lab Space for COVID-19 Research
LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, announced that it is offering free, fully-equipped BL2 lab space, tissue culture facilities, and related resources for researchers working on diagnostics, therapeutics, and other biomedical projects that seek to address the global COVID-19 crisis. This offer is available to the scientific community-at-large including for-profit and non-profit organizations, companies, and academic researchers on a selective, term-limited basis.
Contact
Posted Wednesday, April 1
Innoplexus AG has made its Ontosight AI search platform available for free to all medical researchers fighting COVID-19
Ontosight® enables pharmaceutical, CRO, biotech, and life sciences professionals to accelerate research and development, with real-time insights at their fingertips. Ontosight® modules and dashboards help to significantly accelerate processes throughout the drug development cycle, from preclinical and clinical to regulatory and commercial phases.
Contact
Posted Tuesday, March 31
U.S. Pharmacopeia (USP) offers support for developers of COVID-19 antiviral drugs and vaccines
The USP is making its scientific teams available to help developers ensure the quality of their materials as they scale up manufacturing to bring products into the clinical environment as well as to design tests that ensure quality of materials. USP is extending the support to manufacturers of treatments for secondary implications of the outbreak (e.g. bacterial infections) to help facilitate a greater supply of these critical medicines. USP scientific teams are prepared to assist with solutions in numerous areas. Examples include: 1) Best practices that are broadly applicable to manufacturing and testing strategies and are aligned with global regulatory guidelines, includes test methods and procedures (e.g., sterility testing, bacterial contamination control) that can be used to manage regulatory expectations. 2) Qualification of excipients and raw materials to be used in manufacturing. 3) Our collection of USP Reference Standards which contain materials to demonstrate the suitability of the methods and can also be used for the development and validation of analytical methods. 4) Technical assistance to those who are interested in following our processes and use our standards. We are happy to engage in further dialog with stakeholders to ensure that their approaches to analytical methods can meet compendial and regulatory expectations.
Contact
Posted Tuesday, March 31
C² PHARMA opens government and research access to safety stock of DIGOXIN API for use in potential COVID-19 combination treatment.
As the leading manufacturer of Digoxin API for the pharmaceutical industry, C2 PHARMA holds safety stocks to ensure supply as a standard operating procedure. Based on initial findings of ongoing research, the company has decided to open its safety stocks of Digoxin API to governments and to the global research community in order to meet any peaks in demand. In parallel, C2 PHARMA is offering samples of Digoxin API free of charge to bona fide members of the research community and clinicians working on COVID-19 efficacy trials.
Contact
Posted Tuesday, March 31
Complimentary COVID-19 risk assessment package available to all at no cost
The CluePoints platform includes a mature online Risk Assessment solution that can be leveraged for performing risk assessment and mitigation planning during this crisis. Our team of experts have also developed a special coronavirus-specific Risk Assessment template that includes a set of relevant risk categories and associated considerations gleaned from the regulatory guidance documents issued by FDA, EMA and MHRA.
Contact
Posted Tuesday, March 31
FDAQRC'S sister company, The Orange Report, is offering a discount on remote audits.
COVID Travel Ban Effecting Your Audits? FDAQRC’s sister company; The Orange Report can provide remote audits now! Limited time offer – save $4,000 off remote audits with discount code (COVIDremote).
Contact
Posted Tuesday, March 31
Ginkgo commits $25M of free access to our platform for partner COVID-19 projects
Ginkgo is offering $25M of no-cost foundry work towards projects that can use Ginkgo’s platform to accelerate development of point of care diagnostics, vaccines, or therapeutics. They are also offering connection to sources of funding from private and public sources, and rapid sharing of R&D information as it is learned among the community of academics and companies working on solutions.
Contact
Posted Tuesday, March 31
PCI Pharma Services' newly acquired Bellwyck facility in Toronto is available for local packaging services
For Canadian pharma/biotech companies - PCI Pharma Services' newly acquired Bellwyck facility in Toronto is available for local packaging services, allowing your preparation for Clinical Supply Launch to continue, without the need to cross the US border.
Contact
Posted Tuesday, March 31
Free research compliance resources during COVID-19 crisis
Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis. This includes complimentary transfer of IRB oversight, access to a new version of Forte eRegulatory management software, eReg Lite, and a dedicated “Ask Advarra” resource for rapid guidance on emerging issues impacted by COVID-19.
Contact
Posted Tuesday, March 31
ERT is offering discounted vaccine eDiary product for companies developing Vaccines for COVID-19
ERT is offering immediate and discounted access to their vaccines eDiary platform. They're also making it easy for patients to continue participating in clinical research with fewer site visits through our virtual trial competencies.
Contact
Posted Tuesday, March 31
Veeva is helping small pharma and biotech continue study start up and prepare for the post-COVID restart
The COVID-19 pandemic has made planning for future clinical studies very difficult. In addition to helping the industry as a whole, Veeva is now helping emerging life sciences companies continue study start up and manage the increased financial pressures of this time. Veeva is offering our small Pharma and Biotech customers access to its Vault EDC product for free during this time and is sharing the risk of service-related costs to build these studies. If you have an upcoming study impacted by COVID-19, please reach out. We can help you make progress. Please contact us if you are interested in learning more: [email protected]
Contact
Posted Tuesday, March 31
Taconic Biosciences Supports Coronavirus Research Announces Preclinical COVID-19 Research Tools
Taconic Biosciences, a global leader in providing drug discovery animal model solutions, is supporting COVID-19 research efforts via a new Coronavirus Toolkit. The toolkit models models are grouped by application: COVID-19 disease models, antibody development and production, and vaccine research and development. The toolkit includes several proprietary models, one example being an Ace2 knockout mouse available to Taconic through our partnership with inventor Lexicon Pharmaceuticals. Ace2 knockout mice are used to study acute respiratory distress syndrome (ARDS), a COVID-19 complication. Taconic and Lexicon have partnered to scale production of this strain with subsidized distribution to researchers worldwide. A second example includes genetically humanized HLA (human leukocyte antigen) mice, which are better able to model human vaccine response compared to standard mice. Finally, Taconic is one of only a few companies in the world which can produce humanized immune system mice on scale, which carry human immune cells in a mouse. Beyond models, Taconic’s colony management solutions also offer relief to laboratories faced with restrictions, staff reductions, or temporary closures. Cryopreservation services are offered at a highly competitive price to ensure the security of valuable genetically modified models for the future.
Contact
Posted Tuesday, March 31
ClinCapture, Inc. to Provide Free Electronic Data Capture (EDC) for Clinical Researchers Investigating the Treatment of COVID-19 Coronavirus
ClinCapture, Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, is offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus
Contact
Posted Tuesday, March 31
Trifecta Clinical to Donate Training Services for All Clinical Studies Evaluating the Treatment of COVID-19 Coronavirus
Trifecta Clinical is offering waived training certification fees for pharmaceutical companies sponsoring clinical trials for COVID-19. companies researching COVID-19 can elect to conduct clinical trial training via online broadcast to areas significantly impacted by travel constraints or investigator meeting cancellations. The Trifecta team is ready to immediately assist remote aspects of any training to support critical COVID-19 studies.
Contact
Posted Wednesday, July 29
Ephicacy offers discounted, best-in-class biostatistics and statistical programming to support sponsors in their fight against COVID-19
We provide discounted, best-in-class biostatistics and statistical programming services by our expert team using validated tools in a secure environment. We are currently providing services to a pharma company related to COVID study and we would be glad to extend our services at a discounted pricing to organizations in our support to fight against this pandemic. • Ephicacy has been a trusted clinical service provider for several major pharma, bio-tech companies offering data-oriented services including clinical data management, statistical programming and end-to-end biostatistics services using licensed SAS v9.4 software powered by robust processes and secure computing environment ensuring compliance in meeting the regulatory needs. • Our expert team of biostatisticians and statistical programmers are experienced in handling various phases, therapeutic areas including vaccines and medical device projects.
Contact
Posted Tuesday, July 21
Algorics offers a complimentary review of new and ongoing protocols for COVID-19 clinical trials, to assess if they are robust to the data processing and statistical challenges presented by the pandemic
Algorics is offering a free protocol review to support early stage biopharma customers who are designing and running COVID-19 trials. Early stage biotech sponsors who are not sure how the COVID-19 pandemic could impact their new or ongoing trials, for example the consequences of the missing patient data, will benefit from an independent review of their protocol. What is included in the analysis? • Statistical review of COVID-19 protocols for the impact of the pandemic on the capture and analysis of data – with a focus on safety data • Recommendations on how to update the protocol and suggested areas to monitor as the trial progresses
Contact
Posted Tuesday, July 14
Integrated drug discovery partner with extensive small molecule virology experience targeting drug delivery by oral or inhalation routes
Delivered two respiratory related compounds to clinical trials and two preclinical assets. Recent projects include identifying, synthesising, testing and optimising molecules to accelerate potential Covid-19 treatments to the clinic. Sygnature Discovery, a leading integrated drug discovery CRO, offers a range of services across medicinal and computational chemistry, in vitro and in vivo pharmacology as well as DMPK. Since 2011, 31 compounds discovered by Sygnature have entered pre-clinical development; so far, 15 of these have progressed to clinical trials.
Contact
Posted Friday, June 26
COVID Antigens and free Transposase licenses
As a key supplier for the urgent development of COVID-19 diagnostics, vaccines and therapeutics, ATUM has been working around the clock on custom projects and now offers off-the-shelf catalog reagents. By applying the ATUM gene synthesis platform, mammalian protein production and Leap-In Transposase® mediated Cell Line Development, ATUM accelerates your development with both custom and ready-to-ship reagents.
Contact
Posted Monday, June 15
ConvergeHEALTH by Deloitte Waives Licensing Fees for MyPath for Clinical for COVID and COVID-Impacted Trials
To support the life sciences industry now facing challenges conducting clinical trials during the COVID-19 pandemic, ConvergeHEALTH by Deloitte today announced it is waiving all licensing fees for MyPath for Clinical for current COVID-19 related clinical trials, as well as any current clinical trial impacted by COVID-19. MyPath for Clinical is a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials.
Contact
Posted Monday, May 25
Accelsiors CRO provides a full-service support for COVID-19 studies, having hands-on insight about centers, patient availability and accelerated regulatory approval process
As a full-service, global and scientifically oriented CRO, Accelsiors has been managing phase 1 to phase 3 clinical trials since 2002. Operating in more than 40 countries across 5 continents, we are supporting studies from protocol design and statistical input, through study management and monitoring until submission for marketing authorization. Broad experience with Vaccines, Respiratory and Infectious diseases indications. Currently conducting COVID-19 studies, we have deep understanding of the outbreak circumstances and status of COVID-19 centers and hospitals, as well as access to the patients in all affected regions, both in Europe and US. Direct experience with accelerated regulatory approval, which allows us to conduct all the start-up activities within a minimal time frame. With implementation of our proven methodologies which contain elements of Remote monitoring as well as Central Monitoring (i.e. data analytics), and Risk-based monitoring with partial SDV, we are focusing on the critical data, allowing us to efficiently detect any discrepancies and potential risks at the site level.
Contact
Posted Monday, May 25
SubjectWell is offering free access to our registry of volunteers for COVID-19 trials, a growing patient registry of individuals in the US interested in participating in clinical trials for a COVID-19 vaccine as these trials become more widely available
With SubjectWell’s COVID-19 patient registry, researchers will have access to interested individuals who could randomize for various types of trials, whether they are healthy volunteers with no previous exposure to COVID-19, currently sick with the virus, or those who have recovered. Patient data includes general demographic information, existing medical conditions, past virus diagnoses, past exposure to the virus and results of positive antigen tests. This free access gives researchers the ability to sidestep the lengthy process of identifying participants for a clinical trial. The list will dramatically accelerate last patient in (LPI), which could ultimately bring a safe, approved vaccine to the general public faster.
Contact
Posted Friday, May 22
Digital Twin - personalized PKPD modeling to secure and fasten drug repurposing against Covid-19
ExactCure's "Digital Twin" provides personalized PKPD simulations of new or repurposed drugs based on patient's characteristics (age, weight, renal status, genotype, etc.). We help spot outliers early during clinical trials in phases 2b & 3, thereby reducing attrition rate. Later we can provide a "Digital Companion" to the marketed drug ("Beyond the pill" services + get Real World Evidence + correlate Patient Reported Outcomes to the blood concentration of the drug). The goal is to avoid under-doses, overdoses and drug-drug interactions, as well as to improve adherence. For Covid-19, we have released personalized simulators of lopinavir/ritonavir, hydroxychloroquine, paracetamol. Tocilizumab and a few others are almost ready. We are working on 15 additional drugs with Elsevier’s PharmaPendium®.
Contact
Posted Friday, May 22
SAS launches free AI-driven environment to mine COVID-19 research
Globally, thousands of scientists are working tirelessly on COVID-19 mitigation efforts, including the search for new treatments and a vaccine. Analytics leader SAS brings a powerful resource to the fight with COVID-19 Scientific Literature Search and Text Analysis, a free visual text analysis environment that uses artificial intelligence (AI) and machine learning to quickly search tens of thousands of research articles on COVID-19 and deliver potentially lifesaving answers to these scientists.
Contact
Posted Wednesday, May 20
COVID-19 Drug Development, vaccine and diagnostic kits development services
At Labtoo, we are Experts in outsourcing R&D project management. We are working with more than 500 partners across Europe, providing services in discovery, preclinical R&D and regulatory testing. A specific version of our matching platform was developed during the crisis. We also started a dedicated COVID-19 concierge service aiming to support Biotech companies in their outsourcing processes: 1) Validation of project. 2) CRO or Academic Lab identification. 3) Support for the contracting process: quotation, IP, CDA, MTA, etc. 4) Negotiation.
Contact
Posted Tuesday, May 19
Expert statistical support and analytical consultancy - at discounted rates
Despite the globally felt urgency to find a cure for COVID-19, it is imperative that studies adhere to scientific methods and the resultant data are analysed in a scientifically sound way, generating robust statistical evidence. Protocol development and study set up, tasks that would normally take months, need now to be accomplished in weeks. Supporting such rapid study start up requires statisticians with expert skills, experience and flexibility. If you need statistical help with protocol development, interim analysis or DSMBs you can count on Numerus’s team of statisticians, programmers and epidemiologists to support you. We are here to help, and happy to share our knowledge and expertise in clinical statistics and analytical methodology.
Contact
Posted Thursday, May 14
UK consortium launches COVID-19 Protein Portal to provide essential reagents for SARS-CoV-2 research
A new initiative, led by Wellcome and UKRI, will allow UK scientists to access protein reagents needed for critical research relating to SARS-CoV-2 free of charge from a consortium of leading protein production laboratories.
Contact
Posted Tuesday, May 12
Cloud-based platform for automated analysis of COVID-19 NGS data
Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research. Combining the unique features of the different experimental sequencing kits available for SARS-CoV-2 detection (either metagenomics or amplicon based), we maximize the information extracted from each single experiment performed in a reliable, sensitive and automated way. Our platform helps hospitals, clinics and research laboratories in transforming raw data into interpretable clinical information that will help manage this pandemic, without the need for computational infrastructures or bioinformatics expertise.
Contact
Posted Monday, May 11
Free Encapsia software licenses for COVID-19 studies and any assigned resources and hosting costs can be provided on a Not For Profit basis
Encapsia is purpose-built for modern, smart, clinical trials with fast database build, flexible data capture and loading options, plus live visualizations of aggregated data to deliver technical data science to our customers. Clinical Trials involving hospitalized COVID-19 patients present unique challenges. Encapsia addresses these by enabling collection of clinical trial data via eSource on an iPad – easy to use for bedside data capture under strict infection management, where access to conventional data capture devices is limited. EDC and lab data are also collected into the same database in real-time. Inbuilt, visualizations of live trial data and metadata provide rapid feedback for stakeholders and the study team for faster decision-making. We are committed to rapidly build and deploy study databases for COVID-19 trials. We will flexibly partner with any organisation in the common fight against COVID-19 and provide encapsia via software as a service. Cmed Technology is the developer of encapsia, an innovative, powerful, next-generation clinical data suite. Learn more by clicking the link below.
Contact
Posted Friday, May 8
Offering Arcinova’s experience and expertise in accelerating the development and manufacture of potential treatments for COVID-19
Arcinova can help fast-track the scientific and industrial response to the COVID19 pandemic. With a single site covering drug substance, formulation, drug product, analytical and bioanalytical expertise, we are well positioned to accelerate pharmaceutical development with limited tech transfer delays. We have prior experience in developing anti-virals medicines, including the bioanalysis of patient samples containing highly infectious agents (we have both BSL3 and BSL2 labs in our facility).
Contact
Posted Wednesday, May 6
Free viral epitopes visualization tool and AI-powered platforms
Ardigen is a Life Science computational partner in the era of Artificial Intelligence. We provide comprehensive services that leverage our domain knowledge and expertise in bioinformatics, machine learning and software engineering together with our proprietary technology. We are offering: 1) Free of charge tool - visualizes the SARS-CoV-2 virus proteome structure and allows to display identified viral epitopes on the corresponding regions of the virus. 2) Customized, in silico drug discovery tools - enable improved drug development and data analysis utilizing bioinformatics and AI-powered approaches e.g small RNA design platform, computer vision algorithms, drug repurposing and virtual screening models, drug properties prediction model, drug efficacy and efficiency prediction with a statistical learning approach. 3) Microbiome Translational Platform - enables a novel, powerful approach to the design and development of microbiome-derived therapeutics and diagnostics. 4) ArdImmune Vax Platform - enables a unique approach to selecting immunogenic epitopes for viral vaccines, as well as cancer vaccines and adoptive cell therapies development targeting shared and personalized neoantigens.
Contact
Posted Wednesday, May 6
Smart COVID-19 clinical trial search
Antidote Match is the first trial matching engine that uses structured eligibility criteria (using industry standard and custom-designed ontologies) and proprietary algorithms to explore a patient’s eligibility for every trial. When searching COVID-19 trials, patients answer a handful of questions about their health, and the Antidote Match engine traverses all COVID-19 trials in ClinicalTrials.gov, regardless of location, to connect them with the right studies. This search technology is offered free of charge on Antidote's website and the websites of 250+ patient-facing organizations and nonprofits.
Contact
Posted Friday, May 1
Covid Clinical Coldchain Compliance
va-Q-tec offers reliable, high perfomance single use and pay-per-use cold chain packaging solutions to maintain temperature stability during transportation and handling. Deep frozen, refrigerated and CRT temperature ranges are part of our worry-free, passive cold chain solutions. Please call or email us for a Free consultation specifically for your emerging Covid 19 clinical trials developments.” (insert contact info. here) Specific to Covid 19 many new R&D projects and clinical trials are launching. Sponsors, CMO's , CDMO's and others use our cold chain packaging to insure quality and regulatory compliance when shipping to sites. If you’d like to discuss how to maintain a compliant cold chain, you may contact [email protected] M: (267) 858-1865 with your emerging Covid 19 clinical trials developments or temperature controlled test kit shipment packaging needs.
Contact
Posted Friday, May 1
TransPerfect Life Sciences Announces Free Access To Trial Interactive Central And Remote Monitoring Solutions For Study Teams Impacted By COVID-19
In response to COVID-19, TransPerfect is offering access to Trial Interactive's Study Document Collaboration and myTI mobile application free of charge: 1) A central, shared workspace and portal with secure, 21 CFR Part 11 compliant access 2) Storage of redacted subject source documents 3) Access for all CRAs to do remote and central monitoring 4) A mobile app and workspace that enables site personnel to directly submit subject records to the site portal 5) A dedicated study email to send documents to the portal inbox 6) An iOS and Android mobile app, myTI, to scan documents and directly upload them to the study portal 7) Access to controlled direct upload by site personnel where only their respective site files can be viewed 8) The ability to fax documents directly to the portal
Contact
Posted Thursday, April 30
Career advice and help finding a job at a company working on COVID-19
Barrington James is a global life science recruitment consultancy, we specialise in helping life science professionals plan their careers and help them find the perfect next role. During these challenging times we would be happy to provide advice and support. Whether you have been made redundant and need a new role or are motivated to move to a company that is working to help solve Covid-19.
Contact
Posted Thursday, April 30
CAS releases open access dataset of antiviral chemical compounds to aid COVID-19 discovery and analysis
CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19. In support of calls to action from the White House Office of Science and Technology Policy and innovation leaders around the globe, CAS just released an open access dataset of chemical compounds with known or potential antiviral activity to support research, data mining and analytics applications.
Contact
Posted Monday, April 27
ClinCloud is supporting COVID-19 clinical research and virtual screenings via ClinCloud's Memoirs mobile app
ClinCloud Clinical Research site is fully staffed and operational during the COVID-19 pandemic. We are on-board to accelerate finding treatments, improved testing, and investigational vaccines. We continue to see patients in-clinic that are currently enrolled in a research study. We are dedicated to following the guidelines from the CDC, Florida Department of Health, and health care advisers, to process updates and plan strategies for our clinic. ClinCloud has taken a series of steps to maintain a level of hygiene and cleanliness for the health of the people we serve and our employees. During this time of COVID-19, we see the importance of clinical research and how it remains a priority. We will continue to provide quality services and support the people we serve during this challenging time. This may include virtual visits, phone visits, and more. The ClinCloud team is dedicated to offering new and innovative solutions for our community and fellow research sites. We continue pre-screening prospective patients virtually with the ClinCloud Memoirs mobile app. available on both Android and iOS.
Contact
Posted Monday, April 27
IBM offering free access to patent portfolio to combat COVID-19
In the spirit of such innovation, IBM, the leading U.S. patent recipient for each of the last 27 years, is granting free access to its considerable patent portfolio to those developing technologies to help diagnose, prevent, contain or treat coronaviruses, including the one that causes COVID-19. Our pledge covers thousands of IBM AI patents, including Watson technology patents, as well as dozens of active U.S. patents in the general area of biological viruses.
Contact
Posted Thursday, April 23
Firma Clinical Research offers home health visits for COVID-19 study participants
Firma Clinical’s Home Health Visits are helping provide continuity for COVID-19 studies. Firma offers in-home and alternative location services for study participants, and we are aligned with the latest FDA, NHS and EMA guidelines for patient safety and data protocols for clinical trials during public health emergencies like COVID-19. Firma is committed to a patient-centric approach that supports positive outcomes in the drug development process. Our Home Health Visits advance safety measures, minimize burden, improve retention and maximize protocol compliance. We also are ready to advance new decentralized research with a home health component.
Contact
Posted Tuesday, April 21
LKF provides services for the analysis of Coronavirus (SARS-COV-2-PCR and antibody tests)
LKF – Laboratorium für Klinische Forschung, member of GBA Group Pharma, was founded in 1991 and has more than 25 years of experience as a specialized medical laboratory supporting clinical trials of phase I-IV. Scientific advice, generation of trial specific lab manuals, provision of study specific lab kits, organization of worldwide kits and specimen logistics and a comprehensive analytical service (safety panel, biomarkers, PK) are our core competencies. With the implementation of the new assays for the detection of SARS-COV-2 by PCR and the respective antibody tests we are ready for your COVID-19 trial. All services are performed in house enabling a professional, flexible and fast approach. This allows us to set-up a COVID-19 trial within one week from receiving the clinical trial protocol until delivery of lab kits to the intensive care units.
Contact
Posted Friday, April 17
Clinion is happy to offer discounted Clinion platform licenses for Covid 19 studies to support the global race for a COVID-19 treatment/vaccine
Clinion is a validated, Robust and Secure e-Clinical platform designed to Optimize User Experience by integrating operations and data management and providing state-of-the-art analytics. For additional information, please visit http://www.clinion.com or contact us at [email protected]
Contact
Posted Friday, April 17
Full service CRO with 40 bed cpu for COVID-19 vaccine and diagnostic trials
Located in the NY/NJ metro area, TKL Research has unwillingly been placed in a COVID-19 epicenter, and we are doing our part to assist and combat this virus by any means necessary. While our own principal investigators are battling the virus on the front lines at hospitals nearby, we have a 40 bed pharmacology unit, four outpatient clinics, thousands of healthy volunteers and vaccine experience. In this rapidly evolving pandemic, our leadership team meets daily to stay informed on the ever-changing safety protocols in order to keep our studies running smoothly and our volunteers healthy. We are positioned to be the best fit for a phase I vaccine trial or other COVID-19 treatment alternatives. We have the ability to run your phase I study and carry it through to it’s final approval with our full service CRO capabilities and highly experienced team. We are focused, flexible and able to swiftly make changes in order to meet study requirements and changing safety guidelines. We are your solution.
Contact
Posted Thursday, April 16
ASKE Solutions is ready to provide clinical research and logistical support services to help in the fight against COVID-19
Based in central Texas, ASKE Solutions, LLC provides a variety of support services for clinical trials around the world. We specialize in biological sampling kit design, assembly and distribution, Investigational Product blinding, repackaging, storage and distribution, and biological specimen and retention sample storage. We want to help and are offering our services in support of projects targeting COVID-19 at a reduced rate. Please contact us at [email protected]
Contact
Posted Wednesday, April 15
Elligo Health Research offering patient access solutions
As the ultimate healthcare-enabling research organization, the mission of Elligo Health Research has always been to bring clinical research directly to clinical healthcare, solving patient access challenges by enabling research as a care option. We have been project-managing and staffing drive-thru COVID-19 test sites since mid-March. With access to over two million patients, Elligo has approved efforts to support vaccines, treatment, and testing across our community of sites. Currently, various sites within our network have been at the epicenter of the outbreak and through our existing capabilities, we immediately expanded our efforts to provide solutions to contribute to ongoing, crucial efforts to fight the COVID-19 pandemic: 1) Decentralized or hybrid model for clinical research 2) Full and secure remote monitoring capabilities powered by our proprietary eSource/CTMS platform, IntElligo Research Stack™ Technology 3) Access to diverse patient pools including less populated areas with a high potential of COVID-19 cases and areas with no current access to testing 4) Centralized, remote chart review to minimize patient interaction, operationalize the study, and conduct patient identification 5) Trial Oversight: Elligo’s project leadership, made up of experienced Project Management (PM) and Project Director (PD) staff ensure consistency in trial execution and clarity in sponsor communication, including consistent training for all sites in the network
Contact
Posted Wednesday, April 15
CRMG offers clinical operations expertise during the COVID-19 pandemic
Since 1997, CRMG has provided biotech and pharma companies with tailored support for all phases of clinical development. During this unprecedented time, we offer our expertise to those working toward solutions for the COVID-19 pandemic. We offer a wide range of clinical operations and regulatory support, with internal experts and a broad network of qualified consultants. Our services include: 1) Study Start Up - Available services include protocol development, site identification & feasibility, site start-up & training. Our emphasis is on quality and speed, getting your trial up and running ASAP. 2) Study Conduct - Available services include project management, clinical monitoring, and site management. During this uncertain time, our experience with remote clinical monitoring is particularly valuable, including already developed plans, procedures & templates to support GCP-compliant remote clinical monitoring. 3) Study Close-out - site payments, IP accountability, and regulatory auditing. CRMG ensures that your study remains FDA and GCP compliant throughout, and ends with thorough quality control of your records. 4) Drug Distribution - CRMG's top of the line drug distribution center is housed on-site and includes temperature & humidity controlled ambient, refrigerated, and frozen storage, with environmental monitoring, alarms, and back up generator. Drug distribution turnaround time is 24 hours.
Contact
Posted Tuesday, April 14
Free patient recruitment support
Finding participants for COVID-19 clinical trials quickly is crucial. No one can afford slow patient recruitment. As a leader in patient recruitment, Patient Advertising Guru is seeking opportunities to help by offering our services at no cost. We will waive our fees for any project to find participants for any COVID-19-related clinical trial (testing, vaccine, treatment, etc.). Whether it be traditional advertising (television, radio, print) or online (search marketing, social media, Hulu, etc.) or any marketing initiative, Guru has the expertise to assist and we will charge no fees.
Contact
Posted Tuesday, April 14
We at Viedoc Technologies would be happy to be a part of accelerating the development of treatments for COVID-19
To help increase the speed of vaccine research, we have put together an offer to reduce barriers in the race for a vaccine. We know Viedoc is perfectly matched to the challenge for fast and flexible set-ups and with solutions that are famously easy to learn. The COVID-19 pandemic has quickly become the world's greatest challenge. Viedoc Technologies is here to face that challenge together with the scientific community by waving ordinary license fees. Viedoc is a comprehensive cloud-based platform built to improve the efficiency of conducting clinical trials. EDC, RTSM, and ePRO services are part of the Viedoc eClinical suite. Since 2003 Viedoc has been used in over 2 000 trials in more than 70 countries in all therapeutic areas and clinical phases. Created by industry professionals with decades of experience, Viedoc blends innovation with design to simplify your workday. Our mission is to be at the forefront of eClinical innovation by developing new, smarter ways to help all our clients succeed. Viedoc meets all applicable regulatory standards, including ICH GCP, 21 CFR part 11, and HIPAA. Viedoc Technologies has offices around the world. With our headquarters in Uppsala, Sweden, we also have offices in Philadelphia, Tokyo and Shanghai.
Contact
Posted Tuesday, April 14